Primary tabs

Perspectives

Accelerated approval of anticancer drugs: a safe choice?

All oncologists know how anxiously cancer patients look forward to the availability in clinical practice of drugs that have yielded positive results in the registration trials.

[more]
Archive

Focus on

Medication review and deprescribing: from theory to implementation in different care settings
Medication review and deprescribingThe increase in life expectancy and the growing availability of effective drugs for the management of chronic diseases are leading to an increase in the number of patients, suffering of multimorbidity, in polypharmacotherapy (regular intake of at least five...
[more]
Archive

Columns

Drugs & Elderly
Safety of drugs in the elderly population in Italy
In recent years, the concept of deprescribing has been introduced, based on the reduction of the number of drugs taken in order to optimize the risk-benefit ratio of polypharmacy taking into account the goals of treatment and the preferences of the patient; however, the available intervention...
[more]
Archive

From regulatory agencies

19 September 2024 CADTH
Le rapport cout/efficacité et l’impact budgétaire du nirmatrelvir-ritonavir dans le traitement de la COVID-19
19 September 2024 CADTH
delgocitinib
18 September 2024 FDA
Bionpharma Inc. Issues Voluntary Nationwide Recall of Atovaquone Oral Suspension Due to Bacterial Contamination
18 September 2024 FDA
Tracheostomy Tube Recall: Smiths Medical Removes Certain Bivona Neonatal/Pediatric and Adult Tracheostomy Tubes due to Manufacturing Defect that May Cause Tracheostomy Displacement or Decannulation
17 September 2024 CADTH
Examen des lignes directrices sur le traitement de deuxième intention de la sclérose en plaques cyclique : mise à jour 2024
17 September 2024 CADTH
isatuximab
17 September 2024 FDA
Zimmer Biomet CPT Hip System Femoral Stem and Increased Risk of Thigh Bone Fracture - FDA Safety Communication
16 September 2024 FDA
Infusion Pump Administration Set Recall: Fresenius Kabi USA Removes Certain Ivenix Large Volume Pump Primary Administration Sets
12 September 2024 FDA
FDA Adds Warning About Rare Occurrence of Serious Liver Injury with Use of Veozah (fezolinetant) for Hot Flashes Due to Menopause. Stop Medicine if Signs and Symptoms of Liver Injury Occur - Drug Safety Communication
12 September 2024 CADTH
téprotumumab
Link 
80.211.154.110